Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEART

Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEART

Background: A cardiovascular (CV) hospitalization is a seminal opportunity to implement guideline-directed medical therapy (GDMT). Sodium-glucose transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1RAs) can improve outcomes among those with type 2 diabetes mellitus...

Full description

Saved in:
Bibliographic Details
Main Authors: Wade Thompson, PharmD, PhD, Brendan Wong, MD, Atul Sivaswamy, MSc, Laura Ferreira-Legere, MScN, Douglas S. Lee, MD, PhD, Husam Abdel-Qadir, MD, PhD, Dennis T. Ko, MD, MSc, Alanna Weisman, MD, PhD, Sheldon Tobe, MD, MSc, Cynthia A. Jackevicius, PharmD, MSc, Shaun G. Goodman, MD, MSc, Michael E. Farkouh, MD, Jacob A. Udell, MD, MPH
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X25001064
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X25001064

Similar Items